Long-term reestablishment of alpha-L-iduronidase activity in MPS I fibroblasts after non-viral gene transfer
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder due to deficiency of alpha-L-iduronidase (IDUA). Limitations such as need of weekly injection, high morbidity and mortality and high cost of the current treatments show the need for new approaches to treat this disease. In this wo...
Main Authors: | Fabiano de Oliveira Poswar, Fabiana Quoos Mayer, Maira Graeff Burin, Ursula da Silveira Matte, Roberto Giugliani, Guilherme Baldo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS)
2017-12-01
|
Series: | Clinical and Biomedical Research |
Subjects: | |
Online Access: | http://seer.ufrgs.br/hcpa/article/view/74048 |
Similar Items
-
Long-term reestablishment of alpha-L-iduronidase activity in MPS I fibroblasts after non-viral gene transfer
by: Fabiano de Oliveira Poswar, et al.
Published: (2017-12-01) -
Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
by: Luning Sun, et al.
Published: (2011-01-01) -
Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
by: Luning Sun, et al.
Published: (2011-01-01) -
Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial
by: Roberto Giugliani, et al.
Published: (2018-07-01) -
Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
by: Tatiana Pineda, et al.
Published: (2014-01-01)